In Search of an Algorithm to Prevent Acute Kidney Injury

JACC: Cardiovascular Interventions

Volumn 2, Issue 11, 2009, Pages 1125-1127

  Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

acute kidney injury; coronary angiography; N acetylcysteine; sodium bicarbonate

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; FENOLDOPAM; FUROSEMIDE; MANNITOL; PLACEBO;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; DRUG EFFICACY; EDITORIAL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REHYDRATION; TREATMENT OUTCOME;

ACETYLCYSTEINE; ALGORITHMS; CLINICAL PROTOCOLS; CONTRAST MEDIA; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FREE RADICAL SCAVENGERS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SODIUM BICARBONATE; TREATMENT OUTCOME;

EID: 70449497737     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.08.019     Document Type: Editorial

References (15)

1. Brown J.R., Block C.A., Malenka D.J., O'Conner G.T., Schoolwerth A.C., and Thompson C.A. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. J Am Coll Cardiol Intv 2 (2009) 1116-1124
2. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
3. Tepel M., Aspelin P., and Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113 (2006) 1799-1806
4. Solomon R.J., Mehran R., Natarajan M.K., et al. Contrast-induced nephropathy and long-term adverse events: cause and effect?. Clin J Am Soc Nephrol 4 (2009) 1162-1169
5. Stacul F., Adam A., Becker C.R., et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98 (2006) 59K-77K
6. Meier P., Ko D.T., Tamura A., Tamhane U., and Gurm H.S. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med 7 (2009) 23
7. Navaneethan S.D., Singh S., Appasamy S., Wing R.E., and Sehgal A.R. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 53 (2009) 617-627
8. Hogan S.E., L'Allier P., Chetcuti S., et al. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 156 (2008) 414-421
9. Brar S.S., Shen A.Y., Jorgensen M.B., et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 300 (2008) 1038-1046
10. Meyer M., LeWinter M.M., Bell S.P., et al. N-acetylcysteine-enhanced contrast provides cardiorenal protection. J Am Coll Cardiol Intv 2 (2009) 215-221
11. Kelly A.M., Dwamena B., Cronin P., Bernstein S.J., and Carlos R.C. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148 (2008) 284-294
12. Briguori C., Colombo A., Violante A., et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25 (2004) 206-211
13. Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354 (2006) 2773-2782
14. Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
15. Ochoa A., Pellizzon G., Addala S., et al. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. J Interv Cardiol 17 (2004) 159-165